Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 23517414)

1.

Tumour necrosis factor-α inhibitor use in patients with psoriasis with organ transplantation.

Mansouri B, Patel M, Menter A.

Br J Dermatol. 2013 Aug;169(2):481-3. doi: 10.1111/bjd.12326. Review. No abstract available.

PMID:
23517414
2.

Drug survival rates for tumour necrosis factor-α antagonists in psoriasis.

Burden AD.

Br J Dermatol. 2011 May;164(5):940-1. doi: 10.1111/j.1365-2133.2011.10355.x. No abstract available.

PMID:
21518327
3.

Switching biologicals: switching TNFalpha antagonists in psoriasis treatment.

Schmitt-Egenolf M.

Dermatology. 2008;216(4):281-2. doi: 10.1159/000113939. Epub 2008 Jan 29. No abstract available.

PMID:
18230974
4.

Psoriasis vulgaris associated with acne vulgaris: differential effects of biologicals?

Colsman A, Sticherling M.

Acta Derm Venereol. 2008;88(4):418-9. doi: 10.2340/00015555-0451. No abstract available.

5.

[Supplement series 1: psoriasis updates. Journées Dermatologiques de Paris. Paris, December 8-12, 2009. Foreword].

Cribier B.

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):1-2. doi: 10.1016/S0151-9638(10)70009-0. French. No abstract available.

PMID:
20510164
6.

New biologics for psoriasis and psoriatic arthritis.

Rozenblit M, Lebwohl M.

Dermatol Ther. 2009 Jan-Feb;22(1):56-60. doi: 10.1111/j.1529-8019.2008.01216.x. Review.

PMID:
19222517
7.

Developments in systemic immunomodulatory therapy for psoriasis.

Berger EM, Gottlieb AB.

Curr Opin Pharmacol. 2007 Aug;7(4):434-44. Epub 2007 Jul 12. Review.

PMID:
17627886
8.

Anti-tumor necrosis factor therapy for inflammatory bowel disease in the setting of immunosuppression for solid organ transplantation.

El-Nachef N, Terdiman J, Mahadevan U.

Am J Gastroenterol. 2010 May;105(5):1210-1. doi: 10.1038/ajg.2010.33. No abstract available.

PMID:
20445523
9.

[Prescription and surveillance of treatment by a systemic agent or biotherapy in psoriasis].

Boulinguez S.

Ann Dermatol Venereol. 2010 Apr;137(4 Suppl):8-12. doi: 10.1016/S0151-9638(10)70011-9. Review. French. No abstract available.

PMID:
20510169
10.

[Psoriasis in the era of biologics].

Torres T, Velho GC, Sanches M, Selores M.

Acta Med Port. 2010 May-Jun;23(3):493-8. Epub 2010 Jun 14. Review. Portuguese.

11.

Long-term data in the treatment of psoriasis.

Thaçi D.

Br J Dermatol. 2008 Aug;159 Suppl 2:18-24. doi: 10.1111/j.1365-2133.2008.08781.x. Review.

PMID:
18700911
12.

Pediatric psoriasis: updates in biologic therapies.

Sukhatme SV, Gottlieb AB.

Dermatol Ther. 2009 Jan-Feb;22(1):34-9. doi: 10.1111/j.1529-8019.2008.01214.x. Review.

PMID:
19222515
13.

Current biologic treatments for psoriasis.

Gottlieb AB, Kardos M, Yee M.

Dermatol Nurs. 2009 Sep-Oct;21(5):259-66, 272; quiz 267. Review.

PMID:
19873691
14.

Safety of anti-tumour necrosis factor-α agents in psoriasis patients who were chronic hepatitis B carriers: a retrospective report of seven patients and brief review of the literature.

Fotiadou C, Lazaridou E, Ioannides D.

J Eur Acad Dermatol Venereol. 2011 Apr;25(4):471-4. doi: 10.1111/j.1468-3083.2010.03754.x. Review.

PMID:
20561122
15.

[Long-term safety and efficacy of etanercept in the treatment of psoriasis].

Zaragoza V, Pérez A, Sánchez JL, Oliver V, Martínez L, Alegre V.

Actas Dermosifiliogr. 2010 Jan-Feb;101(1):47-53. Spanish.

PMID:
20109392
16.

Can early treatment with biologicals modify the natural history of comorbidities?

Vena GA, Vestita M, Cassano N.

Dermatol Ther. 2010 Mar-Apr;23(2):181-93. doi: 10.1111/j.1529-8019.2010.01313.x. Review.

PMID:
20415826
17.

QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing anti-tumour necrosis factor alpha therapy.

Desai N, Raste Y, Cooke NT, Harland CC.

Br J Dermatol. 2008 May;158(5):1137-8. doi: 10.1111/j.1365-2133.2008.08457.x. Epub 2008 Feb 15. No abstract available.

PMID:
18279462
18.

Does anti-tumour necrosis factor-alpha increase oral candida colonization? A case-control study in psoriatic patients.

Corazza M, Zauli S, Ricci M, Borghi A, Rossi R, Virgili A.

Acta Derm Venereol. 2013 May;93(3):352-3. doi: 10.2340/00015555-1469. No abstract available.

19.

Tumour necrosis factor-α antagonists in patients with concurrent psoriasis and hepatitis B or hepatitis C: a retrospective analysis of 17 patients.

Prignano F, Ricceri F, Pescitelli L, Zanieri F, Lotti T.

Br J Dermatol. 2011 Mar;164(3):645-7. doi: 10.1111/j.1365-2133.2010.10140.x. Epub 2011 Feb 7.

PMID:
21375517
20.

Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.

Kamarashev J, Lor P, Forster A, Heinzerling L, Burg G, Nestle FO.

Dermatology. 2002;205(2):213-6.

PMID:
12218252
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk